Showing results (531-540 of 556) with videos related to
Sort By:
Pageof 56
Journal of Neurology|January 15, 2025
Longitudinal visual outcomes in idiopathic intracranial hypertension: the role of early prognostic indicators and risk stratification in disease managementBlake D Colman, Paul G Sanfilippo, Anthony Fok, et al.Advanced Drug Delivery Reviews|August 19, 2023
Long-acting microneedle formulationsLalitkumar K Vora, Akmal H Sabri, Yara Naser, et al.Science (New York, N.Y.)|March 16, 2013
Spin torque-generated magnetic droplet solitonsS M Mohseni, S R Sani, J Persson, et al.Frontiers in Neurology|June 15, 2026
Delphi consensus on the real-world application of the updated diagnostic and treatment guidelines for migraine in Asia PacificCharles Hua Chiang Siow, Shengyuan Yu, Surat Tanprawate, et al.Elife|April 30, 2025
Engineering cardiolipin binding to an artificial membrane protein reveals determinants for lipid-mediated stabilizationMia L Abramsson, Robin A Corey, Jan L Skerle, et al.International Journal of Pharmaceutics|August 29, 2024
Transdermal delivery of bisphosphonates using dissolving and hydrogel-forming microarray patches: Potential for enhanced treatment of osteoporosisAnastasia Ripolin, Fabiana Volpe-Zanutto, Akmal H Sabri, et al.Academic Medicine : Journal of the Association of American Medical Colleges|November 1, 1996
Preserving medical schools' academic mission in a competitive marketplaceA M Fogelman, L D Goode, B L Behrens, et al.Multiple Sclerosis and Related Disorders|June 5, 2020
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 yearsJiwon Oh, Anat Achiron, Elisabeth G Celius, et al.Frontiers in Immunology|November 3, 2018
Intestinal CD103+CD11b+ cDC2 Conventional Dendritic Cells Are Required for Primary CD4+ T and B Cell Responses to Soluble FlagellinAdriana Flores-Langarica, Charlotte Cook, Katarzyna Müller Luda, et al.Neurology|February 3, 2017
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MSRichard A Nash, George J Hutton, Michael K Racke, et al.Pageof 56